trending Market Intelligence /marketintelligence/en/news-insights/trending/bsbIQxReHkIanJ_7UMzQEg2 content esgSubNav
In This List

Alliance Pharma adds 2 directors

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Alliance Pharma adds 2 directors

Alliance Pharma PLC has appointed Jo Le Couilliard and Richard Jones as nonexecutive directors to the board, effective Jan. 1, 2019.

Le Couilliard has served as a nonexecutive director of Circassia Pharmaceuticals PLC since Feb. 13. She was also senior vice president, global commercial transformation at GlaxoSmithKline PLC. In addition, she served as a nonexecutive director of the Frimley Park Hospital NHS Foundation Trust.

Jones is CFO of Mereo BioPharma Group PLC, a clinical-stage biopharmaceutical company. Previously, he was CFO of Shield Therapeutics PLC, a specialty pharmaceutical company.

Chippenham, U.K.-based Alliance Pharma operates as a specialty pharmaceutical company.